Variant report
Variant | nsv974469 |
---|---|
Chromosome Location | chr14:83093259-83097863 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2798373 | chr14:83093264-83093265 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs144080534 | chr14:83093279-83093280 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377258348 | chr14:83093281-83093282 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs35760307 | chr14:83093328-83093329 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111711843 | chr14:83093370-83093371 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570243060 | chr14:83093376-83093377 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183510748 | chr14:83093424-83093425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559302016 | chr14:83093498-83093499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs59192239 | chr14:83093596-83093597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187894355 | chr14:83093607-83093608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553080583 | chr14:83093630-83093631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189996718 | chr14:83093632-83093633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116774608 | chr14:83093644-83093645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76220509 | chr14:83093667-83093668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575849884 | chr14:83093723-83093724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17117104 | chr14:83093733-83093734 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs565190212 | chr14:83093737-83093738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549734463 | chr14:83093788-83093789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532305215 | chr14:83093789-83093790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16608533 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma | 21080181 | CNVD |
Gastric cancer | 16891809 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:83092000-83093400 | Enhancers | Brain Cingulate Gyrus | brain |
2 | chr14:83092600-83093400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr14:83093200-83093400 | Flanking Active TSS | Brain Hippocampus Middle | brain |
4 | chr14:83093200-83093400 | Flanking Active TSS | Brain Substantia Nigra | brain |
5 | chr14:83093400-83093800 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr14:83093400-83093800 | Enhancers | Brain Substantia Nigra | brain |